Seres Therapeutics (MCRB) Reports Q1 Loss of $0.59

Seres Therapeutics (NASDAQ: MCRB) reported Q1 EPS of ($0.59), versus ($0.69) reported last year. Revenue for the quarter came in at $7.3 million, versus $3.97 million reported last year.

For earnings history and earnings-related data on Seres Therapeutics (MCRB) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• BofA lists top 5 themes driving next $1tn in incremental semi sales
• CVG to join Russell 2000 and Russell 3000 indexes June 26